Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New magnet device could zap away back pain without pills

NCT ID NCT07652944

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a wand-like magnetic device (HiVE) to see if it can reduce chronic low back pain without medication. About 88 adults with back pain for at least 12 weeks will be randomly assigned to receive either real or fake magnetic stimulation, plus daily home exercises. The goal is to measure pain levels and daily function over 5 to 10 visits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
peripheral magnetic stimulation device (HiVE)
What this could lead to
If it works, this could offer a drug-free option to reduce chronic back pain and improve daily function.
What could go wrong
This is an early-stage trial with only 88 people, so results may not apply to everyone. The device may not reduce pain more than exercise alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 88 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 64 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with chronic low back pain (greater than or equal to 12 weeks) with or without concurrent neck pain. * Low back pain in the paraspinal region (L1-S2) by asking the patient to point to their area of pain. * 18 - 64 years old (on the day of informed consent) * Willing and able to attend all study visits. * No medication changes for at least 30 days before study enrollment (self-report) * Eligible for care at participating military treatment facilities * Able to read and understand English. * Negative pregnancy test for women capable of pregnancy. Exclusion Criteria: * Diagnosed with low back pain of less than 12 weeks duration * History of back fractures or surgical repair of the back * History of depression with vagus nerve stimulation * Any type of transcranial magnetic stimulation (TMS), or rPMS treatment prior to study enrollment. * Currently using any other adjunctive treatments for chronic back pain such as low-level laser treatment, ultrasound, dry needling, chiropractor manipulations, cervical collars, TENS units, or other stimulation, eastern medicine regimens including Qi Gong or Tai Chi. (Exception: strength building physical therapy, non-neuropathic pain modifiers, and non-anticonvulsant routine pain medicine regimens such as NSAIDS and Acetaminophen are allowed).Scheduled for nerve ablation, dry needling, trigger point injections, nerve block, therapeutic ultrasound, other stimulation, or similar adjunct treatments during the study period. * Diagnosed with a specific low back pain: osteoarthritis, rheumatoid arthritis, phantom limb pain, central pain syndrome, spinal cord damage, myofascial pain syndrome, or other more specific diagnosis (at investigators discretion). * Unstable or poorly controlled mental health diagnosis (e.g., current changes in medication or medical management). * Dermal or subdermal implants (e.g., aneurysm clips, shunts, stimulators, ferro magnetic implants, stents, or electrodes, or pacemakers) or any other metal object within or near the site of stimulation which cannot be safely removed. * Clinically significant abnormality or clinically significant unstable medical condition that, in the investigator's judgment, might pose a potential safety risk to the subject or limit interpretation of the trial results. * Any condition which, in the judgment of the investigator, would prevent the patient from completing study procedures. * Pregnancy * Younger than 18 years old (on the day of informed consent) * Older than 64 years old (on the day of informed consent) * NOT willing or able to attend all study visits. * Medication changes for back pain less than 30 days prior to study enrollment (self-report) * NOT eligible for care at participating military treatment facilities * NOT able to read and understand English.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lower back pain chronic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • 412 Medical Group

    RECRUITING

    Edwards Air Force Base, California, 93524, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.